Provided by Tiger Trade Technology Pte. Ltd.

Pfizer

26.43
+0.58002.24%
Post-market: 26.39-0.0403-0.15%19:59 EST
Volume:60.36M
Turnover:1.59B
Market Cap:150.27B
PE:15.31
High:26.65
Open:25.82
Low:25.81
Close:25.85
52wk High:27.69
52wk Low:20.92
Shares:5.69B
Float Shares:5.68B
Volume Ratio:1.37
T/O Rate:1.06%
Dividend:1.70
Dividend Rate:6.43%
EPS(TTM):1.73
EPS(LYR):1.42
ROE:10.60%
ROA:5.19%
PB:1.62
PE(LYR):18.64

Loading ...

Pfizer Partners with YaoPharma to Develop GLP-1 Obesity Drug

Reuters
·
Dec 09

Pfizer - Agreement for Development of Yp05002 Glp-1 Receptor Agonist

THOMSON REUTERS
·
Dec 09

Pfizer - Plans Combination Studies of Yp05002 With Gipr Antagonist

THOMSON REUTERS
·
Dec 09

Pfizer - Yaopharma to Receive $150 Mln Upfront and $1.935 Bln in Milestones

THOMSON REUTERS
·
Dec 09

Weight-Loss Drugs Enter "Volume-for-Value" Phase: Consumerization Trend Accelerates as Lower Prices Stimulate Massive Demand

Deep News
·
Dec 09

Drugmakers Are Ditching Middlemen to Sell Directly to Patients -- WSJ

Dow Jones
·
Dec 09

Pfizer Says Hympavzi Reduced Bleeds by 93% Compared With On-Demand Treatment in Phase-3 Study

MT Newswires Live
·
Dec 08

Eli Lilly, Pfizer Feature in China's Commercial Insurance Innovative Drug Catalog

MT Newswires Live
·
Dec 08

Eli Lilly (LLY.US), Johnson & Johnson (JNJ.US), and Pfizer (PFE.US) Expand in China: Innovative Drugs Included in First Commercial Insurance List

Stock News
·
Dec 08

Pfizer Reports HYMPAVZI Cuts Bleeds by 93% in Hemophilia Patients with Inhibitors

Reuters
·
Dec 07

Hympavzi® (Marstacimab) Reduced Bleeds by 93% Compared to on-Demand Treatment in Adults and Adolescents With Hemophilia a or B With Inhibitors

THOMSON REUTERS
·
Dec 07

Pfizer Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Dec 04

Pfizer Price Target Announced at $26.00/Share by Citigroup

Dow Jones
·
Dec 02

Valuation Soars 25x! This Biotech Bets on IPO with Pfizer and Novo Nordisk's Coveted cAMP Tech

Deep News
·
Dec 02

Pfizer : Citigroup Resumes Coverage With Neutral Rating; Target Price $26

THOMSON REUTERS
·
Dec 02

U.S., U.K. Strike Deal on Higher Drug Prices -- WSJ

Dow Jones
·
Dec 02

EMA Validates Pfizer and Astellas Type II Variation Application for PADCEV and KEYTRUDA in Muscle-Invasive Bladder Cancer

Reuters
·
Dec 02

Pfizer Inc. to Provide Full-Year 2026 Financial Guidance in Analyst Webcast

Reuters
·
Dec 01

FDA's Prasad Cites Alleged Child COVID Shot Deaths in Push for Stricter Rules

Benzinga_recent_news
·
Nov 30

Pfizer (PFE) Gets a Hold from Wells Fargo

TIPRANKS
·
Nov 28